MAPT and Alzheimer disease: In AD, several lines of evidence have suggested that GVDs appear within the hippocampal pyramidal neurons when phosphorylated tau begins to aggregate into early-stage NFTs [11], [15], [18], [31]; however, whether one can adapt this relationship to non-AD diseases had not yet been systematically examined [42].